However, the beneficial effects on glucose and insulin levels did not reach statistical significance, leaving the precise role of FGF21 in human glycemic control unclear [ 81 , 82 ].
← all excerpts
Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target.
2
—
—
The sentences
MASLD: Epidemiology and Diagnosis Globally, the introduction of new diagnostic criteria for MAFLD/MASLD has led to an increasing trend in the prevalence of the disease, estimated at 50.4% between 2006 and 2019, with the highest prevalence in Europe, Asia, and North America [ 4 ].